 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Medical News FDA Grants Tentative Approval for Aurobindo's Antiretroviral Drug AbacavirMay 25, 2006 Indian drug manufacturer Aurobindo Pharma has received tentative approval from FDA to produce 300 mg tablets of abacavir sulfate, which is used in combination with other antiretroviral drugs to treat HIV-1 infection, the company announced on Tuesday, the Hindu Business Line reports. Abacavir is the generic version of GlaxoSmithKline's Ziagen. The product will be eligible for consideration under the President's Emergency Plan for AIDS Relief, according to a press release from the company (Hindu Business Line, 5/24). Back to other news for May 25, 2006
 This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
|
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
